AtriCure, Inc.
corporate_fare Company Profile
AtriCure, Inc. (NASDAQ:ATRC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for ATRC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for ATRC spans 10-Q, 8-K, 8-K/A, DEF 14A.
Recent high-impact activity:
- AtriCure 10-Q: Q3 Revenue $154.5M, First Nine-Month Profit, $260M SentreHEART Suit Detailed
- AtriCure Beats Growth Bar With 15% Revenue Rise, Raises Full-Year Outlook to $610M
- AtriCure Q3 Revenue Up 15% to $154.5M; Full-Year Guidance Set at $606-610M
- AtriCure Swings to Q2 Profit on 12.8% Revenue Growth; SentreHEART Lawsuit Seeks $260M
- AtriCure Swings to Profit in Q2, Raises Full-Year Profitability Outlook
Financial Snapshot
Short Interest & Short Volume
7.60 days to coverFINRA reported short interest of 4,889,793 shares in ATRC as of the October 30, 2026 settlement, a 0.1% increase from the prior period — about 7.6 days to cover at its recent average daily volume. On November 20, 2026, 68.2% of ATRC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.